Multiplicity adjustments in parallel-group multi-arm trials sharing a control group: Clear guidance is needed
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiplicity adjustments in parallel-group multi-arm trials sharing a control group: Clear guidance is needed
Authors
Keywords
Multi-arm, parallel-group clinical trials, Multiplicity, Type 1 error, Family-wise error rate (FWER)
Journal
Contemporary Clinical Trials
Volume 113, Issue -, Pages 106656
Publisher
Elsevier BV
Online
2021-12-12
DOI
10.1016/j.cct.2021.106656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Collaborative platform trials to fight COVID‐19: methodological and regulatory considerations for a better societal outcome
- (2021) Olivier Collignon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials
- (2021) Chengxing Lu et al. Therapeutic Innovation & Regulatory Science
- Current statistical considerations and regulatory perspectives on the planning of confirmatory basket, umbrella and platform trials
- (2020) Olivier Collignon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Potential Statistical Issues Between Designers and Regulators in Confirmatory Basket, Umbrella, and Platform Trials
- (2020) Scott M. Berry CLINICAL PHARMACOLOGY & THERAPEUTICS
- Commentary on Parker and Weir
- (2020) Frank Bretz et al. Clinical Trials
- Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justification
- (2020) Richard A Parker et al. Clinical Trials
- Controlling type I error rates in multi‐arm clinical trials: A case for the false discovery rate
- (2020) James M. S. Wason et al. PHARMACEUTICAL STATISTICS
- Multiplicity issues for platform trials with a shared control arm
- (2020) Xiaofei Bai et al. Journal of Biopharmaceutical Statistics
- On the need to adjust for multiplicity in confirmatory clinical trials with master protocols
- (2019) N Stallard et al. ANNALS OF ONCOLOGY
- New Guidelines for Statistical Reporting in the Journal
- (2019) David Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recommendations on multiple testing adjustment in multi-arm trials with a shared control group
- (2016) Dena R Howard et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- More multiarm randomised trials of superiority are needed
- (2014) Mahesh K B Parmar et al. LANCET
- Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
- (2014) James M S Wason et al. Trials
- Reporting of analyses from randomized controlled trials with multiple arms: a systematic review
- (2013) Gabriel Baron et al. BMC Medicine
- Planning multi-arm screening studies within the context of a drug development program
- (2013) James M. S. Wason et al. STATISTICS IN MEDICINE
- Some recommendations for multi-arm multi-stage trials
- (2012) James Wason et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Multiplicity adjustments in trials with two correlated comparisons of interest
- (2010) Nikki Fernandes et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Multi-Arm Clinical Trials of New Agents: Some Design Considerations
- (2008) B. Freidlin et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now